Loading…

Johnson & Johnson announced that its subsidiary Ethicon has agreed to acquire Auris Health for approximately $3.4 billion in cash, with additional contingent payments up to $2.35 billion. Auris Health develops robotic technologies for bronchoscopic procedures.
“We believe the combination of best-in-class robotics, advanced instrumentation and unparalleled end-to-end connectivity will make a meaningful difference in patient outcomes.”jnj.com
Summarized from public sources; check the original articles before acting on it.